Skip to content
Roboearth – Lifestyle
Author:
Tempest Therapeutics
Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors
June 4, 2026
Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds
May 29, 2026
Tempest Reports Year End 2025 Financial Results and Provides Business Update
March 30, 2026
←
Previous Page
1
2